Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Sino Biopharmaceutical
Pharmaceutical Preparation ManufacturingHong Kong SAR ChinaPNK: SBMFF
Last verified 26 days agosinobiopharm.com
Sino Biopharmaceutical Limited, commonly referred to as Sino Biopharmaceutical, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Hong Kong. Established in 1996, the company has made significant strides in developing innovative medicines, particularly in the fields of oncology, cardiovascular, and central nervous system disorders.
With a robust presence in major operational regions across China and expanding internationally, Sino Biopharmaceutical is renowned for its commitment to research and development. The company’s core products include a diverse range of prescription medications and therapeutic solutions, distinguished by their high quality and efficacy.
Sino Biopharmaceutical has achieved notable market recognition, positioning itself among the top pharmaceutical manufacturers in China, and continues to drive advancements in healthcare through its dedication to innovation and excellence.
33
DitchCarbon score
-9 vs industry average
Sino Biopharmaceutical’s score of 33 is lower than 45% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sino Biopharmaceutical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Sino Biopharmaceutical's reported carbon emissions
Sino Biopharmaceutical's Carbon Emissions & Climate Commitments
Hong Kong-headquartered Sino Biopharmaceutical, a pharmaceutical preparation manufacturing company, reported its 2024 Scope 1 and 2 carbon emissions at approximately 208.2 million kg CO2e. This figure includes about 18.2 million kg CO2e from Scope 1 emissions and approximately 190.0 million kg CO2e from Scope 2 emissions.
Historically, Sino Biopharmaceutical's Scope 1 and 2 emissions were around 239.2 million kg CO2e in 2023 and approximately 277.1 million kg CO2e in 2022. For 2021, their Scope 1 and 2 emissions were about 274.9 million kg CO2e, comprising roughly 21.7 million kg CO2e from Scope 1 and 253.2 million kg CO2e from Scope 2. In 2020, total emissions were around 221.7 million kg CO2e, and in 2019, approximately 189.5 million kg CO2e. The company reported total emissions of about 120.4 million kg CO2e in 2018. Scope 3 emissions data is not currently disclosed.
Sino Biopharmaceutical has set a near-term intensity reduction target: to reduce GHG emissions per RMB1 million of revenue by 20% by 2025, using 2021 as the benchmark year. This target covers all scopes of emissions.
Assessing Sino Biopharmaceutical as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Sino Biopharmaceutical and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Sino Biopharmaceutical’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Sino Biopharmaceutical26 days ago
33
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more